
    
      -  Vandetanib will be given to participants in tablet form. The dose taken will depend upon
           when they are enrolled in the study. The doctor will inform them of which dose they are
           on and how many tablets they will be taking.

        -  Sirolimus will also be given to participants in tablet form. The dose taken will depend
           upon when they are enrolled in the study. The dose on the first day will be higher than
           the dose taken every other day.

        -  Participants will also be given Bactrim, one double-strength table three times each week
           (Monday, Wednesday, Friday) to help prevent participants from getting a type of
           pneumonia called pneumocystis pneumonia.

        -  The following tests and procedures will be performed before the participants begin
           taking the study drugs and before every 4 week cycle: Physical exam; medical history;
           questions about any side effects; tumor assessment by MRI or CT (only before every other
           cycle); Mini-Mental Status exam (MMSE); ECG (week 1, 2, 4, 8, 12, then every 3 months
           thereafter); blood pressure; blood tests and urine tests.

        -  Participants will be in this research study for a maximum of 12 months.
    
  